Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medicine /醫學院
  3. Institute of Medicine/醫學研究所
  4. 非輸卵管阻塞性之女性不孕症病因治療
 
  • Details
Options

非輸卵管阻塞性之女性不孕症病因治療

Date Issued
2001
Author(s)
葉柔慶
Yeh Rou ching
Advisor
林隆堯
Lin Loung Eour
URI
https://handle.ncl.edu.tw/11296/d43x5v
https://scholars.csmu.edu.tw/handle/123456789/34928
Abstract
由於基層診所設備不足,卻又往往須面對不孕症治療。今日雖人工助孕生殖技術發達,但往往花費金錢及耗時,病人配合度差,其成功率亦約四成左右,又有OHSS及多胞胎妊娠紋之危險性。故本人利用開業臨床病例67例,分成A、B、C、D四組。依病人之接受度及喜好決定人數,A組只用西醫療法,B組用西醫加中醫,C組用西醫、中醫、外加針灸,D組則只純用中醫方法。用本人所設計之評分做治療性之指標。結果發現A組成功率65%,B組成功率72.2%,C組成功率70.59%,D組成功率58.33%。由圖表中看出A、B於第二、三個月成功率較高,而C組於第一個月成功率較高,D組於第三個月成功率較高。B、C組用針灸成功率差不多,但針灸似乎有使受孕成功提早之作用,利用此評分做指標,發現病人分數接近70分往往能成功季經濟,又能於基層醫療院所用此法。(療程六個月)
I use clinical patient included 67 cases then give them to nfoure group analysis. A group use medical therapy B group use medical therapy with china a medical drug. C group use medical therapy with china a medical drug and Arcupunture. D group just use china medical drug therapy. I find that the 67 cases must use score method and use the score to give me a guide to us what drug suit for patient. After 6 month treatment and care. I get that A group has 65%; B group has 72.2%; C group has 70.59%; D group has 58.33% successful rate. The issue is fit for clinical doctor to threat in fertility about famal.
Subjects
黃體成長激素
卵泡刺激素
人類胎盤激素
人類停經激素
試管嬰兒
禮物嬰兒
卵巢過度刺激症候群
正常月經
LH
PSH
HCG
HMG
IVF
GIFT
OHSS
Eumemenorrhea
Type
thesis
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback